Albireo Pharma Inc (NASDAQ:ALBO)

37.31
Delayed Data
As of Jun 22
 +1.28 / +3.55%
Today’s Change
17.20
Today|||52-Week Range
39.87
+45.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 1
2018
Revenue and IncomeNet Revenues1.0K1.0K0.0011.2M
 
 
 
 
Depreciation And Amortization5.0K8.0K10.0K53.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----10.0K--
 
 
General Expenses6.0M6.7M6.9M10.2M
 
 
 
 
 
Other Operating Expenses74.0K-65.0K-401.0K1.5M
 
 
 
 
 
Research And Development2.8M3.0M3.2M6.2M
 
 
 
 
 
Total Operating Expenses6.1M6.6M6.5M11.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.1M-6.6M-6.5M-581.0K
 
 
 
 
 
Extraordinary Credit0.00609.0K--0.00
 
 
Interest Expense On Debt249.0K152.0K--1.0M
 
 
 
 
Other Expenses-325.0K-24.0K0.00-22.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.7M-6.2M-6.5M-1.6M
 
 
 
 
 
Net Income-6.7M-6.2M-6.5M-1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.3M7.2M8.9M10.9M
 
 
 
 
 
Shares To Calculate EPS Diluted6.3M7.2M8.9M10.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.06-$0.86-$0.73-$0.15
 
 
 
 
 
EPS Diluted-$1.06-$0.86-$0.73-$0.15